Pharmacotherapy for Endocrine and Musculoskeletal Disorders
Order Description
Week 6 Discussion
Increase text size
Decrease text size
Print Page
Pharmacotherapy for Endocrine and Musculoskeletal Disorders
Patients with endocrine and musculoskeletal disorders often require long-term treatment and care resulting in the need for extensive patient education. By appropriately educating patients, advanced practice nurses can assist patients with the management of their disorders. In clinical settings, patients with endocrine and musculoskeletal disorders typically seek treatment for symptoms that pose problems to their everyday lives as ordinary tasks may become difficult to complete. For instance, patients might have difficulty walking short distances, preparing meals, or even running errands. To reduce these symptoms and additional health risks, it is essential to develop drug therapy plans with individual patient factors in mind.
To prepare:
•Select one of the following endocrine or musculoskeletal disorders: thyroid disease, osteoarthritis, rheumatic arthritis, gout, multiple sclerosis, or fibromyalgia. Consider the types of drugs that would be prescribed to patients to treat symptoms associated with this disorder.
•Select one of the following factors: genetics, gender, ethnicity, age, or behavior. Reflect on how this factor might impact the effects of prescribed drugs, as well as any measures you might take to help reduce negative side effects.
********************************************************
Post on or before Day 3 a description of the endocrine or musculoskeletal disorder you selected including types of drugs that would be prescribed to patients to treat associated symptoms. Then, explain how the factor you selected might impact the effects of prescribed drugs, as well as any measures you might take to help reduce negative side effects.
*********************************************************
make sure you address all parts.
Readings
• Arcangelo, V. P., & Peterson, A. M. (Eds.). (2013). Pharmacotherapeutics for advanced practice: A practical approach (3rd ed.). Ambler, PA: Lippincott Williams & Wilkins.
o Chapter 36, “Osteoarthritis and Rheumatoid Arthritis” (pp. 538–559)
This chapter examines the causes, pathophysiology, and diagnostic criteria of osteoarthritis and rheumatoid arthritis. It then outlines the process of selecting, administering, and managing drug therapy for both disorders.
o Chapter 37, “Fibromyalgia” (pp. 560–567)
This chapter explores the causes, pathophysiology, and diagnostic criteria of fibromyalgia. It also covers the process of selecting, administering, and managing drug therapy for this disorder.
o Chapter 45, “Diabetes Mellitus” (pp. 696–714)
This chapter begins by identifying the causes, pathophysiology, and diagnostic criteria of diabetes mellitus. It then examines the process of selecting, administering, and managing drug therapy for patients with diabetes mellitus.
o Chapter 46, “Thyroid Disorders” (pp. 715–729)
This chapter explores the causes, pathophysiology, diagnostic criteria, and administration of drug therapy for patients with thyroid disorders, including hypothyroidism, hyperthyroidism, thyroid nodules, subclinical thyroid disease, and thyroiditis. It also discusses the mechanisms of prescribed drugs, as well as proper dosages and potential adverse reactions.
Ben-Zacharia, A. (2011). Therapeutics for multiple sclerosis symptoms. The Mount Sinai Journal of Medicine, 78(2), 176–191.
Retrieved from the Walden Library databases.
This article covers the diagnosis, treatment, and management of multiple sclerosis and explores methods for treating other health issues that arise from multiple sclerosis.
Kargiotis, O., Paschali, A., Messinis, L., &Papathanasopoulos, P. (2010). Quality of life in multiple sclerosis: Effects of current treatment options. International Review of Psychiatry, 22(1), 67–82.
Retrieved from the Walden Library databases.
This article examines the process of evaluating and diagnosing patients who present with symptoms of multiple sclerosis and explores treatment and rehabilitation methods.
Peterson, K., Silverstein, J., Kaufman, F., & Warren-Boulton, E. (2007). Management of type 2 diabetes in youth: An update. American Family Physician, 76(5), 658–664.
Retrieved from the Walden Library databases.
This article outlines the process of diagnosing, treating, and managing youths with or at risk of type 2 diabetes. It also suggests methods for body weight management and reducing cardiovascular disease risks.
Drugs.com. (2012). Retrieved from http://www.drugs.com/
This website presents a comprehensive review of prescription and over-the-counter drugs including information on common uses and potential side effects. It also provides updates relating to new drugs on the market, support from health professionals, and a drug-drug interactions checker.
Media
• Laureate Education, Inc. (Executive Producer). (2012). The endocrine system and diabetes. Baltimore, MD: Author.
This media presentation explores the endocrine system and diabetes including diagnosis and treatment of the disease.
Note: The approximate length of this media piece is 5 minutes.
• Laureate Education, Inc. (Executive Producer). (2012). Advanced pharmacology – Mid-course review. Baltimore, MD: Author.
This media is an interactive mid-course review covering course content.
This is what the professor had to say about last discussion:
Nice work. My only suggestion is to provide a more complete discussion of the medication classes. You should include how the medications work (MOA), why they work (i.e. relationship to pathophysiology/symptoms), side effects, and strategies to manage side effects. It may help to refer to the class announcements for a complete list of the elements that should be included in drug discussions. It serves as a great checklist to ensure that you have included all the expectations. Thanks for a great discussion this week